Skip to main content

Posts

Showing posts from October, 2020

MCQ. Mavacamten

 Q. Mavacamten was recently assessed and found to be useful in which of the following disease? A. DCMP B. HOCM C. Coronary artery disease with mitral regurgitation D. Amyloidosis Answer: B. HOCM Mavacamten is a medication that relaxes the heart muscle and treats obstructive hypertrophic cardiomyopathy (HCM). It is a small-molecule inhibitor of cardiac myosin that reduces myocardial contractility and improves myocardial energetics.